Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 4 1Phase 3 1Phase 2/3 1

Status

Recruiting 3

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gynecologic 3Other 1

Conditions

Endometrial Neoplasms 3Endometrial Hyperplasia 2Obesity 1

Interventions

Paclitaxel 233Carboplatin 217Bevacizumab 139Cisplatin 134pembrolizumab 89Gemcitabine 69olaparib 54Docetaxel 47Topotecan 44Radiotherapy 43liposomal doxorubicin 41Taxes 41niraparib 38Cyclophosphamide 36Doxorubicin 30Letrozole 28Drug Therapy 28Nivolumab 27Magnetic Resonance Spectroscopy 25Immunoglobulin G 25Disulfides 24Oxaliplatin 23durvalumab 22Albumin-Bound Paclitaxel 22apatinib 21Etoposide 21Brachytherapy 21lenvatinib 20Specimen Handling 20Filgrastim 20

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Progestins × Gynecologic × Clear all
NCT07377734 2026-03-30

2026ColECFerSp

Peking University People's Hospital

Phase 2 Recruiting
30 enrolled
Gynecologic

Endometrial Hyperplasia, Endometrial Neoplasms

NCT05903131 2026-01-20

Uterine Preservation Via Lifestyle Transformation

Washington University School of Medicine

Phase 2 Recruiting
96 enrolled
GynecologicOther

Endometrial Hyperplasia, Obesity, Endometrial Neoplasms

NCT06914297 2025-04-30

TQB2450 Plus Progestin for Fertility-sparing Treatment in MMRd EC

Fudan University

Phase 2 Recruiting
10 enrolled
Gynecologic

Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡